Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Filings indexed 399 across all filing types
Latest filing 2025-06-23 Board/Management Inform…
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
代本公司重要子公司中國化學製藥股份有限公司 公告其總經理異動
Board/Management Information Classification · 100% confidence The document is a short announcement (756 characters) about a change in the general manager of a major subsidiary company. It includes details such as the old and new general manager names, their resumes, the reason for change (retirement), and effective date. There are no financial statements, no report attachments, or references to financial results. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in senior management. The document is not a report itself but an announcement of a management change. Therefore, the correct classification is MANG with high confidence.
2025-06-23 Chinese
114年年報及股東會資料 — 2025_3716_20250527F05.pdf
AGM Information Classification · 95% confidence The document is a detailed record of the Annual General Meeting (AGM) of 中化投資控股股份有限公司 held in the 114th year of the Republic of China calendar (2025). It includes attendance, voting results, discussions on various agenda items such as the 113th year business report, financial statements, dividend distribution, capital increase plans, amendments to company articles, and employee stock rights issuance. The document also contains appendices with the 113th year business report, auditor's report, and financial statements. The presence of detailed meeting minutes, voting results, and discussions indicates this is the official record of the AGM proceedings rather than just a presentation or announcement. Therefore, the document fits the category of AGM Information (AGM-R).
2025-06-13 Chinese
114年年報及股東會資料 — 2025_3716_20250527F17.pdf
Major Shareholding Notification Classification · 95% confidence The document contains detailed information about the top ten shareholders of the company, including their shareholding percentages and relationships among them (e.g., family ties). This type of disclosure is typical of a Major Shareholding Notification, which reports changes or details about significant share ownership levels. The document is relatively short (1416 characters) and does not contain financial statements or management discussion, so it is not an Annual Report or Interim Report. It is not an announcement of voting results, board changes, or legal proceedings. Therefore, the best fitting category is Major Shareholding Notification (MRQ).
2025-06-13 Chinese
114年年報及股東會資料 — 2024_3716_20250527FE4.pdf
Annual Report Classification · 100% confidence The document is titled '2024 Annual Report' and contains detailed sections typical of an annual report, including financial performance, corporate governance, business performance, funding status, and outlook. It includes comprehensive financial data, management discussion, and strategic outlook for the company. The length is substantial (15,000 characters), and it is not merely an announcement or a certification. The presence of detailed financial figures, business review, and governance information confirms it is the full Annual Report itself, not just an announcement or summary. Therefore, the appropriate classification is Annual Report (10-K). FY 2024
2025-06-13 Chinese
114年年報及股東會資料 — 2024_3716_20250527F04.pdf
Regulatory Filings
2025-06-13 Chinese
114年年報及股東會資料 — 2025_3716_20250527FE2.pdf
AGM Information Classification · 95% confidence The document is a detailed agenda and materials for the 2025 Extraordinary General Shareholders’ Meeting of Cenra Inc. It includes meeting procedures, reports such as the 2024 Business Report, Audit Committee’s Review Report, financial statements, proposals for approval of financial statements and profit distribution, discussions on dividend distribution, private placement issuance, amendments to company articles and procedures, and issuance of employee stock options. The content is typical of materials prepared and shared for a shareholders' meeting, including business reports, audit reports, proposals, and governance amendments. The presence of detailed appendices and the structure of the document indicate it is the actual meeting materials, not just an announcement or summary. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting.
2025-06-13 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.